BDBM531339 2-(6-(((1S,2S,5S)-8-(2-Hydroxyethyl)-8-azabicyclo[3.2.1] octan-2-yl)amino)pyridazin-3-yl)-3-methyl-5-(trifluoromethyl)pheno::US11208399, Example 86b

SMILES Cc1cc(cc(O)c1-c1ccc(NC2CCC3CCC2N3CCO)nn1)C(F)(F)F

InChI Key InChIKey=DXZHPZCYSLAGSL-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 531339   

TargetInterleukin-1 beta(Human)
Novartis

US Patent
LigandPNGBDBM531339(US11208399, Example 86b | 2-(6-(((1S,2S,5S)-8-(2-H...)
Affinity DataIC50: 1.80nMAssay Description:Monocytic THP-1 cells (ATCC: TIB-202) were maintained according to providers' instructions in RPMI media (RPMI/Hepes+10% fetal bovine serum+Sodiu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/2/2022
Entry Details
Go to US Patent

TargetTumor necrosis factor(Human)
Novartis

US Patent
LigandPNGBDBM531339(US11208399, Example 86b | 2-(6-(((1S,2S,5S)-8-(2-H...)
Affinity DataIC50: 1.00E+5nMAssay Description:Monocytic THP-1 cells were maintained according to providers' instructions in RPMI media as described above. Undifferentiated cells were plated a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/2/2022
Entry Details
Go to US Patent